معرفی
Takuya Toyonaga is a Research Scientist in the Department of Radiology and Biomedical Imaging at Yale School of Medicine and serves as Co-Medical Director of the Yale Biomedical Imaging Institute. His work is affiliated with the Bioimaging Sciences Center, Center for Brain & Mind Health, and PET Core at Yale. Dr. Toyonaga maintains a strong research profile focused on advanced neuroimaging techniques with clinical applications.
Dr. Toyonaga earned his MD and PhD from Hokkaido University in Japan (2012 and 2017 respectively) followed by a postdoctoral fellowship at Yale School of Medicine (2019). His educational background bridges clinical medicine with advanced imaging research, providing a strong foundation for his current work in molecular imaging and neuroscience.
His primary research focuses on synaptic density imaging using PET technology, particularly with SV2A tracers like [11C]UCB-J. His work spans multiple neurological conditions including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and autism spectrum disorders. Dr. Toyonaga has made significant contributions to methodological advances in PET imaging, including deep learning-based attenuation correction, motion correction techniques, and partial volume correction methods. His research integrates molecular imaging with clinical neuroscience to understand synaptic changes in neurodegenerative and neuropsychiatric disorders.
Analysis of Dr. Toyonaga's publication record reveals a strong trajectory in synaptic density imaging, with increasing sophistication in methodology and expanding clinical applications. His work has evolved from basic tracer development and validation to clinical applications across multiple neurological conditions, with recent emphasis on artificial intelligence approaches to enhance imaging capabilities. The consistent focus on SV2A PET imaging demonstrates his specialization in this emerging field of neuroimaging.
Dr. Toyonaga actively mentors postdoctoral researchers, including Seyed Faraz Nejati, MD, who has been working with him since 2023. His research program likely involves collaboration with multiple laboratories across Yale focused on neuroscience, neurodegenerative diseases, and imaging technology development. While specific grant information isn't provided in the available text, his extensive publication record suggests active funding for his research program.
As Co-Medical Director of the Yale Biomedical Imaging Institute, Dr. Toyonaga plays a key role in overseeing advanced imaging facilities and research programs. His work with the PET Core indicates direct involvement with radiotracer production and imaging protocols. His research bridges basic science, translational imaging, and clinical applications, positioning him at the forefront of synaptic density imaging research.
